Search Within

Michael David Offin

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (57)
  2. Journal Article (50)
  3. Editorial (2)
  4. Correspondence (1)
  5. Review (1)
Groups
  1. Department of Medicine (111)
  2. Department of Pathology and Laboratory Medicine (111)
  3. Solid Tumor Oncology Division (111)
  4. Thoracic Oncology (111)
  5. Weinberg Fellows (111)
  6. GSK Faculty (93)

More Groups

People
  1. Marc Ladanyi (57)
  2. Charles Rudin (56)
  3. Mark Kris (47)
  4. Alexander Drilon (45)
  5. Bob Li (43)
  6. Maria Arcila (42)

More People

Years
  1. 2025 (3)
  2. 2024 (15)
  3. 2023 (8)
  4. 2022 (14)
  5. 2021 (23)
  6. 2020 (9)

More Years

Publications
  1. Journal of Thoracic Oncology (23)
  2. Journal of Clinical Oncology (21)
  3. Clinical Cancer Research (12)
  4. Modern Pathology (8)
  5. JCO Precision Oncology (6)
  6. Laboratory Investigation (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. Elsevier Inc. (27)
  3. American Association for Cancer Research (20)
  4. Nature Publishing Group (8)
  5. Nature Research (8)
  6. Oxford University Press (5)

More Publishers

Results (111)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation of histologic features with gene alterations in pleural mesothelioma
    Journal Article

    Fanaroff, R. E.; Yang, S. R.; Tan, K. S.; Adusumilli, P. S.; Bodd, F.; Bowman, A.; Chang, J.; Offin, M. D.; Reiner, A.; Rekhtman, N.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Chromothripsis-mediated small cell lung carcinoma
    Journal Article

    Rekhtman, N.; Tischfield, S. E.; Febres-Aldana, C. A.; Lee, J. J. K.; Chang, J. C.; Herzberg, B. O.; Selenica, P.; Woo, H. J.; Vanderbilt, C. M.; Yang, S. R.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Combining a WT1 vaccine (Galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1–expressing diffuse pleural mesothelioma: A phase 1 study
    Journal Article

    Agrawal, P.; Offin, M.; Lai, V.; Ginsberg, M. S.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ho, T.; Wong, P.; Zauderer, M. G.
    JTO Clinical and Research Reports (2025)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Exploratory analysis of ctDNA and imaging response in the phase I/II CHORUS study of canakinumab with chemoradiation and durvalumab consolidation for stage Ill NSCLC
    Meeting Abstract

    Shaverdian, N.; Offin, M.; Charalambous, K.; Gelblum, D.; Santini, F.; Boe, L. A.; Shepherd, A. F.; Gewanter, R. M.; Shin, J. Y.; Rimner, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • A model for approaching pathologic assessment of treatment response to neoadjuvant chemotherapy in resected pleural mesothelioma
    Meeting Abstract

    Aly, R. G.; Offin, M.; Tan, K. S.; Bodd, F.; Adusumilli, P.; Travis, W.; Zauderer, M.; Sauter, J.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with well-differentiated papillary peritoneal mesothelial tumors
    Journal Article

    Offin, M.; Aguirre, N.; Yang, S. R.; Sauter, J. L.; Karagkounis, G.; Mohamed, M.; Cercek, A.; Kundra, R.; Zhang, Y.; Wang, H. M.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets
    Journal Article

    Chen, M. F.; Yang, S. R.; Tao, J. J.; Desilets, A.; Diamond, E. L.; Wilhelm, C.; Rosen, E.; Gong, Y.; Mullaney, K.; Torrisi, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save